Target intelligence / Profile preview

Phenolic compounds and bile salts in the gut lumen

Molecular classification
Metabolites, Dietary compounds, Steroids, Lipids
01

Overview

The term "Phenolic compounds and bile salts in the gut lumen" refers to a complex biochemical environment and set of interactions rather than a single therapeutic target. Bile salts are endogenous steroid detergents synthesized from cholesterol in the liver and secreted into the intestine to facilitate the digestion and absorption of dietary lipids (Hofmann & Hagey, 2006, "The evolutionary biology of bile salts"). Phenolic compounds are a diverse group of plant-derived phytonutrients, such as flavonoids and phenolic acids, which can interact with bile salts through hydrophobic binding or by altering the gut microbiota responsible for bile acid deconjugation and dehydroxylation (Oteiza et al., 2018, "Dietary polyphenols and type 2 diabetes"). These interactions can lead to increased fecal excretion of bile acids, thereby lowering systemic cholesterol levels and modulating metabolic signaling through receptors like the Farnesoid X Receptor (FXR). While specific proteins like the Apical Sodium-dependent Bile acid Transporter (ASBT) are valid drug targets, the combination of these substances in the gut lumen represents a physiological process or a dietary-metabolic interface. Consequently, this entry is classified as incorrect for a discrete molecular target, as it encompasses multiple chemical classes and non-specific physical interactions (StatPearls, "Bile Acid Sequestrants").

Other names
Gut luminal phenolic-bile acid complexPolyphenol-bile salt interactionsDietary phenolics and biliary metabolites
02

Mechanism of action

Bile acid sequestration and modulation of the enterohepatic circulation through physical binding or microbial transformation.

03

Biological functions

Lipid emulsificationMicelle formationMicrobiome modulationCholesterol homeostasisAntioxidant activity
04

Disease associations

DyslipidemiaMetabolic syndromeObesityColorectal cancerInflammatory bowel disease
05

Safety considerations

Malabsorption of fat-soluble vitamins (A, D, E, K)Gastrointestinal distress (constipation, bloating)Interference with the absorption of co-administered medications
06

Interacting drugs

Cholestyramine

2 more in the full profile.

07

Biomarkers

Fecal bile acid excretionSerum LDL cholesterol7-alpha-hydroxy-4-cholesten-3-one (C4)Gut microbiota diversity profiles

Beyond the preview

Go deeper on Phenolic compounds and bile salts in the gut lumen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phenolic compounds and bile salts in the gut lumen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call